-
Dr. Zefei Jiang：Toripalimab Plus Nab-Paclitaxel in Metastatic or Recurrent Triple-Negative Breast Cancer: A Randomized Phase 3 Trial
In a significant advancement in cancer research, Dr. Zefei Jiang and his team from The Fifth Medical Center of Chinese PLA General Hospital published the article “Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial” in Nature Medicine(IF=83) on January 1, 2024. This pivotal study investigates the efficacy and…
-
New Insights: IP + IV Paclitaxel Plus S-1 Boosts Survival in Gastric Cancer Patients with Peritoneal Metastasis
Noninvasive intraperitoneal chemotherapy (NIPS) has been explored as a promising treatment approach to enhance drug exposure in peritoneal metastasis while reducing systemic toxicity. Previous studies at our center have investigated…
-
Dr. Yongmei Yin：Efficacy, Safety, and Population Pharmacokinetics of MW032 Compared With Denosumab for Solid Tumor–Related Bone Metastases: A Randomized Double-Blind Phase 3 Equivalence Trial
In a significant advancement in cancer research, Dr. Yongmei Yin and her team from The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital published the article “Efficacy, Safety, and Population Pharmacokinetics of MW032 Compared With Denosumab for Solid Tumor–Related Bone Metastases: A Randomized Double-Blind Phase 3 Equivalence Trial” in JAMA Oncology on April,…
-
Dr. Zefei Jiang Reviews 2023 Advances in Breast Cancer Research
In 2023, significant progress has been made in the field of breast cancer research. Dr. Zefei Jiang from The Fifth Medical Center of Chinese PLA General Hospital shared his insights and research findings at several important conferences. This article summarizes Professor Jiang’s speeches and highlights key advances in breast cancer treatment in 2023.
-
ASCO GI | Advancing Targeted Therapy for Gastric Cancer: Insights from Dr. Anna Dorothea Wagner
Oncology Frontier: Could you please introduce the current status of virtual targeted treatment for gastric cancer? Dr. Anna Dorothea Wagner: It’s my pleasure to respond to this question. Currently, adding…
-
Dr. Zefei Jiang ‘s Overview of Breast Cancer Research Progress in 2023
In 2023, significant progress has been made in the field of breast cancer research. Dr. Zefei Jiang from The Fifth Medical Center of Chinese PLA General Hospital shared his insights and research findings at several important conferences. This article delves into Professor Jiang’s speeches, exploring the key advancements in breast cancer treatment in 2023.
-
Unlocking New Potential: Insights from the LAPIS Phase 3 Trial on Pamrevlumab in Locally Advanced Pancreatic Cancer
Editor’s note: The LAPIS Phase 3 trial was a large-scale, global, double-blind, placebo-controlled study designed to assess the efficacy of pamrevlumab in combination with chemotherapy for patients with locally advanced…
-
The 8th Yunling Breast Cancer Summit Forum | Dr. Qianjun Chen: Focusing on Controversies in HER2-Positive Breast Cancer, Multidisciplinary Collaboration Holds Great Promise
On July 14, to mark the 40th anniversary of Yunnan Cancer Hospital, the “8th Yunling Breast Cancer Summit Forum,” hosted by the Yunnan Anti-Cancer Association and the Chinese Medical Education Association, was held in Kunming. The event gathered cutting-edge advances in breast cancer from domestic and international experts. Dr. Qianjun Chen from Guangdong Provincial Hospital…
Connecting Medical Expertise through Media